These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 3617067)
1. Metabolic and peroxisome proliferation studies with di(2-ethylhexyl)phthalate in rats and monkeys. Short RD; Robinson EC; Lington AW; Chin AE Toxicol Ind Health; 1987 Jun; 3(2):185-95. PubMed ID: 3617067 [TBL] [Abstract][Full Text] [Related]
2. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Marsman DS; Cattley RC; Conway JG; Popp JA Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084 [TBL] [Abstract][Full Text] [Related]
4. The metabolism of mono-(2-ethylhexyl) phthalate (MEHP) and liver peroxisome proliferation in the hamster. Lhuguenot JC; Mitchell AM; Elcombe CR Toxicol Ind Health; 1988 Dec; 4(4):431-41. PubMed ID: 3188042 [TBL] [Abstract][Full Text] [Related]
5. Comparative studies on di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation in the rat and hamster. Lake BG; Gray TJ; Foster JR; Stubberfield CR; Gangolli SD Toxicol Appl Pharmacol; 1984 Jan; 72(1):46-60. PubMed ID: 6710484 [TBL] [Abstract][Full Text] [Related]
6. Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate, and clofibrate in cynomolgus monkeys. Pugh G; Isenberg JS; Kamendulis LM; Ackley DC; Clare LJ; Brown R; Lington AW; Smith JH; Klaunig JE Toxicol Sci; 2000 Jul; 56(1):181-8. PubMed ID: 10869467 [TBL] [Abstract][Full Text] [Related]
7. Studies by the National Toxicology Program on di(2-ethylhexyl)phthalate. Melnick RL; Morrissey RE; Tomaszewski KE Toxicol Ind Health; 1987 Jun; 3(2):99-118. PubMed ID: 3617073 [TBL] [Abstract][Full Text] [Related]
8. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396 [TBL] [Abstract][Full Text] [Related]
9. Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years. Cattley RC; Conway JG; Popp JA Cancer Lett; 1987 Dec; 38(1-2):15-22. PubMed ID: 3690505 [TBL] [Abstract][Full Text] [Related]
10. Effects of Di-2-ethylhexyl phthalate (DEHP) on gap-junctional intercellular communication (GJIC), DNA synthesis, and peroxisomal beta oxidation (PBOX) in rat, mouse, and hamster liver. Isenberg JS; Kamendulis LM; Smith JH; Ackley DC; Pugh G; Lington AW; Klaunig JE Toxicol Sci; 2000 Jul; 56(1):73-85. PubMed ID: 10869455 [TBL] [Abstract][Full Text] [Related]
11. The metabolism of di(2-ethylhexyl) phthalate (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP) in rats: in vivo and in vitro dose and time dependency of metabolism. Lhuguenot JC; Mitchell AM; Milner G; Lock EA; Elcombe CR Toxicol Appl Pharmacol; 1985 Aug; 80(1):11-22. PubMed ID: 4024100 [TBL] [Abstract][Full Text] [Related]
12. Di-n-octyl phthalate (DOP), a relatively ineffective peroxisome inducing straight chain isomer of the environmental contaminant di(2-ethylhexyl)phthalate (DEHP), enhances the development of putative preneoplastic lesions in rat liver. DeAngelo AB; Garrett CT; Manolukas LA; Yario T Toxicology; 1986 Nov; 41(3):279-88. PubMed ID: 2877511 [TBL] [Abstract][Full Text] [Related]
13. In vivo studies on the mechanism of di(2-ethylhexyl)phthalate carcinogenesis. Popp JA; Garvey LK; Cattley RC Toxicol Ind Health; 1987 Jun; 3(2):151-63. PubMed ID: 3303447 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome induction studies on di(2-ethylhexyl)terephthalate. Topping DC; Ford GP; Evans JG; Lake BG; O'Donoghue JL; Lockhart HB Toxicol Ind Health; 1987 Jun; 3(2):63-78. PubMed ID: 3617070 [TBL] [Abstract][Full Text] [Related]
15. Species differences in di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation. Lake BG; Gray TJ; Foster JR; Stubberfield CR; Gangolli SD Dev Toxicol Environ Sci; 1983; 11():595-8. PubMed ID: 6677511 [No Abstract] [Full Text] [Related]
16. Comparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man. Rhodes C; Orton TC; Pratt IS; Batten PL; Bratt H; Jackson SJ; Elcombe CR Environ Health Perspect; 1986 Mar; 65():299-307. PubMed ID: 3086078 [TBL] [Abstract][Full Text] [Related]
17. Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Huber WW; Grasl-Kraupp B; Schulte-Hermann R Crit Rev Toxicol; 1996 Jun; 26(4):365-481. PubMed ID: 8817083 [TBL] [Abstract][Full Text] [Related]
18. Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalate. Popp JA; Garvey LK; Hamm TE; Swenberg JA Carcinogenesis; 1985 Jan; 6(1):141-4. PubMed ID: 2857115 [TBL] [Abstract][Full Text] [Related]
19. Reversibility and persistence of di-2-ethylhexyl phthalate (DEHP)- and phenobarbital-induced hepatocellular changes in rodents. Isenberg JS; Kamendulis LM; Ackley DC; Smith JH; Pugh G; Lington AW; McKee RH; Klaunig JE Toxicol Sci; 2001 Dec; 64(2):192-9. PubMed ID: 11719701 [TBL] [Abstract][Full Text] [Related]